2024-519482-22-00招募中1 期
Phase 1 clinical trial to evaluate the safety, tolerability and pharmacokinetics of multiple daily doses of IM-250 in healthy volunteers.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 12
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Company management
Scientific
Innovative Molecules GmbH
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Phase I clinical trial to evaluate safety, pharmacokinetics and immunomodulatory activity of the capsule formulation of the standardized extract of Atractylodes lanceaone.Atractylodes lanceaPharmacokineticsPhase I clinical trialSafetyImmunomodulatory activityTCTR20201020001ational Research Council of Thailand48
进行中（未招募）
1 期
A study to compare two dosing regimens for a new malaria vaccineMalaria (African strain)Infections and InfestationsISRCTN95289709niversity of Oxford23
招募中
不适用
A phase 1 clinical trial to evaluate the safety and pharmacokinetic characteristics after administration of fixed-dose combination of NGL-101 and loose-combination of each component in healthy adult volunteersKCT0007258Chungbuk National University Hospital40
已完成
不适用
Comparison of pharmacokinetics between administration of fixed-dose combination or loose combination of HUG186(Bazedoxifene and Cholecalciferol)KCT0003839Huons52
未知
1 期
A Phase I clinical trial to investigate the safety and tolerability of NK105 when co-administered with carboplatin once per week to Japanese patients with advanced solid cancers.Advanced solid cancersJPRN-jRCT2080223202ippon Kayaku Co., Ltd.18